Buprenorphine does not aggrevate ischemic neuronal injury in experimental focal cerebral ischemia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 19, Issue 3, 2007, Pages 331-334

  Yulug, Burak ^a   Cam, Ertugrul ^b   Yildiz, Aysegul ^c   Kilic, Ertugrul ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANTAGONIST;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG INDICATION; MAINTENANCE THERAPY; MALE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN INFARCTION; DISEASE MODEL; DRUG SCREENING; LASER DOPPLER FLOWMETRY; METHODOLOGY; PATHOLOGY; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; BUPRENORPHINE; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; LASER-DOPPLER FLOWMETRY; MALE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR;

EID: 85047698574     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2007.19.3.331     Document Type: Article

References (21)

1. Cowan A, Lewis JW, MacFarlane IR: Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 1977; 60:537-545
2. Heel RC, Brodgen RN, Speight TM, et al: Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 1979; 17:81-110
3. Neiman J, Haapaniemi HM, Hillbom M: Neurological complications of drug abuse: pathophysiological mechanisms. Eur J Neurol 2000; 7:595-606
4. Bartolomei F, Nicoli F, Swiader L, et al: Ischemic cerebral vascular stroke after heroin sniffing: a new case. Presse Med 1992; 6:983-986
5. Jensen R, Olsen TS, Winther BB: Severe non-occlusive ischemic stroke in young heroin addicts. Acta Neurol Scand 1990; 81:354-357
6. Brust JC, Richter RW: Stroke associated with addiction to heroin. J Neurol Neurosurg Psychiatry 1976; 39:194-199
7. Belcheva MM, Ho MT, Ignatova EG, et al: Buprenorphine differentially alters opioid receptor adaptation in rat brain regions. J Pharmacol Exp Ther 1996; 277:1322-1327
8. Boutin H, Dauphin F, MacKenzie ET, et al: Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice. Stroke 1999; 30:1271-1277
9. Koizumi J, Yoshida Y, Nakazawa T, et al: Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8:1-8
10. Kugawa F, Ueno A, Aoki M: Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway. Biol Pharm Bull 2000; 23:930-935
11. Kugawa F, Arae K, Ueno A, et al: Buprenorphine hydrochloride induces apoptosis in NG108-15 nerve cells. Eur J Pharmacol 1998; 347:105-112
12. Zabramski JM, Spetzler RF, Selman WR, et al: Naloxone therapy during focal cerebral ischemia evaluation in a primate model. Stroke 1984; 15:621-627
13. Kusomoto K, Mackay KB, McCulloch J: The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischemia. Brain Res 1992; 576:147-151
14. Baskin DS, Widmayer MA, Browning JL, et al: Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats. Stroke 1994; 25:2047-2054
15. Krumins SA, Faden AI: Traumatic injury alters opiate receptor binding in spinal cord. Ann Neurol 1986; 19:498-501
16. Herman BH, Goldstein A: Antinociception and paralysis induced by intrathecal dynorphin A. J Pharmacol Exp Ther 1985; 232:27-32
17. Faden AI, Molineaux CJ, Rosenberger JG, et al: Increased dynorphin immunoreactivity in spinal cord after traumatic injury. Regul Pept 1985; 11:35-41
18. Scavini S, Rozza A, Bo P, et al: Opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits. Stroke 1990; 21:943-947
19. Fallis RJ, Fisher M, Lobo RA: A double blind trial of naloxone in the treatment of acute stroke. Stroke 1984; 15:627-629
20. Perraro F, Tosocini G, Pertoldi F, et al: Double-blind placebo controlled trial of naloxone on motor deficits in acute cerebrovascular disease. Lancet 1984; 1:915
21. Clark WM, Raps EC, Tong TC, et al: Cervene (nalmefene) in acute ischemic stroke: final results of a phase III efficacy study. Stroke 2000; 31:1234-1239